SCHEMBL24534730

SCHEMBL24534730

C=C1N=C(c2ccc(OC(C)=O)cc2)OC1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.50
HSD17B10 Q99714 1/20 0.44
GAPDH P04406 1/20 0.43
LMNA P02545 3/20 0.42
MAPT P10636 5/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 2/20 0.41
ELANE P08246 1/20 0.41
GAA P10253 2/20 0.41
RAB9A P51151 2/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
MAOB P27338 1/20 0.40
MEN1 O00255 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
PKM P14618 2/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24534553 0.81 ALOX5 (0.48) LMNAMAPTKMT2AGAARAB9A
SCHEMBL24534942 0.80 KMT2A (0.49) PTGS2HSD17B10GAPDHMAPTKMT2A
SCHEMBL24534678 0.78 NOTUM (0.44) LMNAMAPTKMT2AGAARAB9A
SCHEMBL24534516 0.77 GSTP1 (0.46) MAPTKMT2APOLBGAARAB9A
SCHEMBL22505144 0.77 ALDH1A1 (0.44) HSD17B10LMNAMAPTRAB9ATSHR
SCHEMBL24534657 0.77 SMN1; SMN2 (0.51) PTGS2HSD17B10MAPTKMT2APOLB
SCHEMBL24241617 0.75 CYP2D6 (0.46) HSD17B10LMNAMAPTRAB9ATSHR
SCHEMBL24534659 0.74 SMN1; SMN2 (0.47) LMNAMAPTKMT2AGAARAB9A
SCHEMBL11120249 0.73 ALOX5 (0.61) MAPTKMT2APOLBGAAMEN1
SCHEMBL15421781 0.73 KMT2A (0.69) MAPTKMT2APOLBMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220193041-A1 NOVEL COMPOUND AND METHOD FOR PREVENTING OR TREATING OF RESPIRATORY DISEASES COMPRISING THE SAME AS AN ACTIVE INGREDIENT Yonsei University, University - Industry Foundation (UIF) (KR) 2022-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220193041-A1 NOVEL COMPOUND AND METHOD FOR PREVENTING OR TREATING OF RESPIRATORY DISEASES COMPRISING THE SAME AS AN ACTIVE INGREDIENT EPX, CFTR, MPO PTGS2 1445/4885HSD17B10 365/4885GAPDH 1529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.